Looking at CST research condition by condition gives a more useful picture than broad systematic reviews alone. Individual trials are noisy, and a single study rarely settles anything. But the pattern of findings across specific conditions starts to suggest where CST may have genuine effects and where the evidence is weaker.
This article summarises what the trials show for migraine, infant colic, neck pain, fibromyalgia, low back pain, and pelvic girdle pain in pregnancy — the conditions with the most active research in the field.
Migraine: two recent positive trials
Migraine is one of the more encouraging areas in recent CST research. A 2022 RCT found significant reductions in pain intensity, headache frequency, disability scores, and medication use in the CST group. A 2023 crossover study added to this picture, also showing positive results on migraine-relevant outcomes. Two positive trials in consecutive years is notable, even allowing for the limitations of individual studies.
Migraine is a condition where the nervous system's sensitivity and the quality of central pain processing matter — which makes CST's proposed mechanism of supporting nervous system regulation at least biologically plausible as a contributing factor. Neither trial proves that CST is a first-line treatment, but the results are specific enough to warrant further investigation, and to give clinicians reasonable grounds to consider it as an adjunct for patients whose migraines aren't well controlled by other approaches.
Infant colic: meaningful reduction in crying
The 2019 infant colic RCT is one of the more well-designed individual trials in the CST literature. With 132 participants, it's adequately powered. The outcome measures — hours of crying per day and sleep quality — are clinically concrete. The CST group showed a reduction of 3.2 hours of crying per day by day 24, alongside improved sleep outcomes. These are clinically meaningful differences in a condition that is distressing for both infants and their families and for which conventional medicine has limited effective interventions.
Colic is also a condition where parents are genuinely motivated to seek help and the demand for safe, effective options is real. The biodynamic community has a strong track record working with unsettled babies, birth trauma, and early developmental challenges, and clinical experience here consistently runs ahead of the formal trial evidence. The 2019 trial gives rigorous support to what practitioners have observed for years.
Neck pain: a sham-controlled trial
The 2015 neck pain RCT (PMID 26340656) is one of the more methodologically careful studies in the field. With 54 patients randomised to CST or sham, it found significant and clinically relevant effects on pain intensity in the CST group. A sham-controlled design matters because it tries to account for the non-specific effects of therapeutic contact, and finding effects against a sham is more meaningful than finding them against no treatment.
The effect sizes were meaningful by standard clinical thresholds, not marginal. For neck pain — a condition that is both very common and often inadequately addressed by available treatments — a well-designed positive trial is worth taking seriously, even alongside broader systematic reviews that have been less definitive.
Fibromyalgia, low back, pelvic girdle
The 2010 fibromyalgia RCT with 92 patients found significant pain reductions at 13 of 18 tender points assessed, which is a specific and objectively measurable outcome. Fibromyalgia involves widespread pain sensitisation and nervous system dysregulation — again, a presentation where CST's proposed effects on the nervous system have some face validity.
Low back pain is more mixed. A 2016 RCT found that the primary endpoint — disability as measured by the Roland Morris Questionnaire — did not reach statistical significance (p = 0.060), though pain intensity did show improvement. Near-miss on the primary outcome: not negative exactly, but not a clear positive either. Pelvic girdle pain in pregnancy fared less well: a 2013 RCT found treatment effects that were small and considered clinically questionable by the study authors. Both areas need better-designed trials with larger samples before conclusions can be drawn with confidence.
The condition-specific evidence is uneven but not without meaningful signals. Migraine, infant colic, neck pain, and fibromyalgia have produced the most encouraging individual trial results. Low back pain and pelvic girdle pain are more ambiguous. A clear-eyed reading supports cautious optimism in some areas while acknowledging the need for better research across all of them.